Literature DB >> 23147547

Primary intracerebral myeloid sarcoma.

Meral Gunaldi1, Ismail O Kara, Berna B Duman, Vehbi Ercolak.   

Abstract

BACKGROUND: Myeloid sarcoma rarely presents in the absence of systemic myeloid disease. CASE REPORT: In this study, we present a case of intracerebral myeloid sarcoma with no diagnosis of any hematological disease in a 22-year-old male patient in whom brain magnetic resonance image revealed a meningioma. However, biopsy showed myeloid sarcoma. No myeloid disease was determined. The mass disappeared following 8 cycles of chemotherapy. In the literature, we determined only 8 similar cases cited between 1970 and 2011.
CONCLUSION: Intracerebral myeloid sarcoma has currently no standard treatment and may be confused with a primary brain disease. Chemotherapy and/or radiotherapy are the most viable and widely used treatment modalities. Potential occurrence of hematological disease should also be closely followed due to conversion risks.

Entities:  

Mesh:

Year:  2012        PMID: 23147547     DOI: 10.1159/000343953

Source DB:  PubMed          Journal:  Onkologie        ISSN: 0378-584X


  3 in total

1.  Use of magnetic resonance imaging for diagnosis and after treatment of patients with myeloid sarcoma of the brain.

Authors:  Xuewen Hou; Longting Du; Haitao Yu; Xiaojin Zhang
Journal:  Oncotarget       Date:  2017-10-13

2.  Intracranial Myeloid Sarcoma Metastasis Mimicking Acute Subdural Hematoma.

Authors:  Amandip S Gill; Rabina Gill; Paul Kaloostian; Dina Elias; John S Roufail; Aurora S Cruz; Panayiotis E Pelargos; Frank P K Hsu; Ronald C Kim; Robert E Ayer; Samer Ghostine
Journal:  Case Rep Surg       Date:  2017-10-22

3.  Isolated Intracranial Myeloid Sarcoma Mimicking Malignant Lymphoma: A Diagnostic Challenge and Literature Reviews.

Authors:  Guixuan Xu; Haijun Zhang; Weixia Nong; Chunsen Li; Lian Meng; Chunxia Liu; Feng Li
Journal:  Onco Targets Ther       Date:  2020-06-25       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.